PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Founded:
2016-04-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Apache Wordpress Plugins
Similar Organizations
Clincierge
Clincierge enables patients to connect more effectively with clinical trials of new medicines.
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.
Current Advisors List
Sean Parker Board Member @ Parker Institute for Cancer Immunotherapy Board_member
Jeffrey Bluestone Board Member @ Parker Institute for Cancer Immunotherapy Board_member
Current Employees Featured
Lewis Lanier
Lewis Lanier Director @ Parker Institute for Cancer Immunotherapy Director 2015-07-01
Susan Schultz
Susan Schultz Vice President of Business Operations @ Parker Institute for Cancer Immunotherapy Vice President of Business Operations 2016-07-01
Sean Parker
Sean Parker Chairman @ Parker Institute for Cancer Immunotherapy Chairman
Crystal Mackall
Crystal Mackall Director, Parker Institute for Cancer Immunotherapy at Stanford @ Parker Institute for Cancer Immunotherapy Director, Parker Institute for Cancer Immunotherapy at Stanford 2016-06-01
Charles Michael Yim
Charles Michael Yim Donor @ Parker Institute for Cancer Immunotherapy Donor 2020-03-01
Jeffrey Bluestone
Jeffrey Bluestone President & CEO @ Parker Institute for Cancer Immunotherapy President & CEO 2015-04-01
Melinda Griffith
Melinda Griffith Vice President Of Strategic Alliance Management & Chief Legal Counsel @ Parker Institute for Cancer Immunotherapy Vice President Of Strategic Alliance Management & Chief Legal Counsel 2016-01-01
Founder
Leo Nissola
Sean Parker
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-06 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series B - ArsenalBio | 220 M USD |
2022-06-09 | Senti Biosciences | Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences | 50.6 M USD |
2022-03-22 | Affini-T Therapeutics | Parker Institute for Cancer Immunotherapy investment in Venture Round - Affini-T Therapeutics | 175 M USD |
2019-10-17 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series A - ArsenalBio | 85 M USD |
2018-04-19 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 35 M USD |
2018-01-23 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 100 M USD |
2017-09-14 | ImaginAb | Parker Institute for Cancer Immunotherapy investment in Venture Round - ImaginAb | 8 M USD |
2015-12-09 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Seed Round - Tmunity Therapeutics | 10 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-07-23 | Parker Institute Adds John Connolly as New Chief Scientific Officer |